ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Blood Cells, Molecules, and Diseases
Volume 34, Issue 3, May-June 2005, Pages 226-228
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (82 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.bcmd.2005.01.001    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2005 Elsevier Inc. All rights reserved.

Iron overload in an African American woman with SS hemoglobinopathy and a promoter mutation in the X-linked erythroid-specific 5-aminolevulinate synthase (ALAS2) gene

James C. Bartona, b, Corresponding Author Contact Information, E-mail The Corresponding Author, Pauline L. Leec, Luigi F. Bertolia and Ernest Beutlerc

aSouthern Iron Disorders Center, Birmingham, AL 35209, USA bDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA cDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA

Received 17 January 2005. 
(Communicated by E. Beutler, M.D., 17 January 2005). 
Available online 23 February 2005.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

We report the case of an African American woman with sickle cell anemia and iron overload incompletely explained by erythrocyte transfusion who is heterozygous for a promoter mutation in the X-linked erythroid-specific 5-aminolevulinate synthase gene (ALAS2): a C to G transversion at nucleotide −206 from the transcription start site, as defined by primer extension (−258 from the start ATG). This mutation has previously been associated with sideroblastic anemia and iron overload in members of a Welsh kinship. No coding region mutation of HFE, FPN1, TFR2, HAMP, or HJV genes was detected. The mother of the proband has mild, chronic anemia and is also heterozygous for the same proximal promoter region mutation of ALAS2. However, she has no evidence of iron overload. We conclude that an ALAS2 promoter region mutation could partly account for iron overload in the present proband, and that this or other ALAS2 mutations could explain the occurrence of iron overload in other whites or blacks with or without anemia. The occurrence of anemia and iron overload may be discordant in women heterozygous for ALAS2 mutations.

Keywords: African American; ALAS2; Hemochromatosis; Iron; Iron overload; Mutation; Promoter; Sickle cell anemia

Article Outline

Introduction
Patient and methods
Case report
Laboratory methods
Discussion
Acknowledgements
References

 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.